COMPANY

Thiogenesis Therapeutics, Inc.

HQ: Toronto, Ontario, Canada source

Keywords: small molecule cystinosis

Location: Toronto, Ontario, Canada · source · Jun 9, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $29K (Form D filed Jun 9, 2026). SEC Form D 0001062993-26-003123 (Jun 9, 2026)
Evidence (1 event)
- Jun 9, 2026 · SEC Form D 0001062993-26-003123
  Name of Issuer: Thiogenesis Therapeutics, Corp.; CIK: 1877778; Address: Ontario, Canada; Submission type: D; Filing date: 2026-06-09; Industry Group: Biotechnology; Date of First Sale: 2026-06-01; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 28964; Total Amount Sold: 28964; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals